4Shipp MA, Abeloff MD, Antman KH, et al. International consensus conference on high-dose therapy with hematopoietic stem cell transplantation in aggressive non-Hodgkin′s lymphomas: report of the jury. J Clin Oncol, 1999, 17:423-429.
5Zwicky CS, Maddocks AB, Anderson N, et al. Eradication of polymerase chain reaction detectable immunoglobulin gene rearrangement in non-Hodgkin′s lymphoma is associated with decreased relapse after autologous bone marrow transplantation. Blood, 1996, 88:3314-3322.
6Leonard B, Hetu F, Busque L, et al. Lymphoma cell burden in progenitor cell grafts measured by competitive polymerase chain reaction: less than one log difference between bone marrow and peripheral blood sources. Blood, 1998, 91:331-339.
7Signoretto S, Murphy M, Cangi MG, et al. Detection of clonal T-cell receptor γ Gene rearramgements in paraffin-embeded tissue by polymerase chain reaction and nonradioactive single-strand conformational polymorphism analysis. Am J Pathol, 1999,154:62-76.
8Baruchel A, Cayuela JM, MacIntyre E, et al. Assessment of clonal evolution at Ig/TCR loci in acute lymphoblastic leukaemia by single-strand conformation polymorphism studies and highly resolutive PCR derived methods:implication for a general strategy of minimal residual disease detection. Br J Haematol, 1995, 90:85-93.
9Pappa VI, Wilkes S, Salam A, et al. Use of the polymerase chain reaction and direct sequencing analysis to detect cells with the t(14;18) in autologous bone marrow from patients with follicular lymphoma before and after in vitro treatment. Bone Marrow Transplant, 1998, 22:553-558.
10Jacquy C, Lambert F, Soree A, et al. Peripheral blood stem cell contamination in mantle cell non-Hodgkin lymphoma: the case for purging? Bone Marrow Transplant, 1999, 23:681-686.
